BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11709548)

  • 1. Perturbation of SUMOlation enzyme Ubc9 by distinct domain within nucleoporin RanBP2/Nup358.
    Saitoh H; Pizzi MD; Wang J
    J Biol Chem; 2002 Feb; 277(7):4755-63. PubMed ID: 11709548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.
    Zhang H; Saitoh H; Matunis MJ
    Mol Cell Biol; 2002 Sep; 22(18):6498-508. PubMed ID: 12192048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
    Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
    Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
    Saitoh H; Sparrow DB; Shiomi T; Pu RT; Nishimoto T; Mohun TJ; Dasso M
    Curr Biol; 1998 Jan; 8(2):121-4. PubMed ID: 9427648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
    Gareau JR; Reverter D; Lima CD
    J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
    Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.
    Patil H; Yoon D; Bhowmick R; Cai Y; Cho KI; Ferreira PA
    Small GTPases; 2019 Mar; 10(2):146-161. PubMed ID: 28877029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nucleoporin Nup358/RanBP2 promotes nuclear import in a cargo- and transport receptor-specific manner.
    Wälde S; Thakar K; Hutten S; Spillner C; Nath A; Rothbauer U; Wiemann S; Kehlenbach RH
    Traffic; 2012 Feb; 13(2):218-33. PubMed ID: 21995724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a substrate recognition site on Ubc9.
    Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
    J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
    Weger S; Hammer E; Engstler M
    Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
    Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
    J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.
    Ritterhoff T; Das H; Hofhaus G; Schröder RR; Flotho A; Melchior F
    Nat Commun; 2016 May; 7():11482. PubMed ID: 27160050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification.
    Kurtzman AL; Schechter N
    Proc Natl Acad Sci U S A; 2001 May; 98(10):5602-7. PubMed ID: 11331779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the human SUMO-1 protease SENP2 with the nuclear pore.
    Hang J; Dasso M
    J Biol Chem; 2002 May; 277(22):19961-6. PubMed ID: 11896061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nuclear export signal in Smad1 is essential for its signaling activity.
    Xiao Z; Brownawell AM; Macara IG; Lodish HF
    J Biol Chem; 2003 Sep; 278(36):34245-52. PubMed ID: 12821673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.